Press Releases

FARMINGTON, Conn., July 16, 2019 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today

NEWARK, Calif., July 16, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on July 15, 2019, it issued an inducement award to Sarita Khanna, Ph.D., the Company's recently hired Vice President of Biostatistics, in accordance with the terms of Dr. Khanna's employment offe

PLYMOUTH MEETING, Pa., July 16, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has sharpened its corporate strategy to focus on the commercial development of its late-stage HPV assets and reallocate capital to develop fast-to-market product candidates. The company has cut selected early-stage R&D programs and discontinue

LOS ANGELES, July 16, 2019 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (OTC: IMUC), today announced an agreement with a privately held biotechnology company (the "Purchaser") for the purchase of substantially all of ImmunoCellular's remaining clinical and pre-clinical assets, including its preclinical and clinical programs, technology, intellect

CLEVELAND, July 16, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of Dr. Gail Wilensky to its Board of Directors, effective today.

WASHINGTON, July 16, 2019 /PRNewswire/ -- The American Pharmacists Association (APhA) has announced that it is launching the Well-Being Index, a validated screening tool inve

PALMER, Mass. and WESTFIELD, Mass., July 16, 2019 /PRNewswire/ -- The state Department of Public Health has found that the intensive care units at Baystate Noble and Wing hospitals are "necessary for preserving access and health" and that Baystate Health must prepare a plan showing how it will maintain services for area residents.

ATLANTA, July 16, 2019 /PRNewswire/ -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, has announced the license and commercialization agreement with ROMEG Therapeutics, LLC, for the exclusive rights to launch Gloperba – an oral solution for adults suffering from gout – in the United States. Gloperba is a

NEW YORK, July 16, 2019 /PRNewswire/ -- WellPath, creators of customized and outcome-focused nutritional solutions, announced today their largest product launch in company history with the release of PURE Apple Cider Vinegar gummies for Amazon's Prime Day Launches initiative.

LOUISVILLE, Ky., July 16, 2019 /PRNewswire/ --  Koligo Therapeutics, Inc. announced that it has made KYSLECEL (autologous pancreatic islets) with a 24-hour expiration time available throughout the United States.  KYSLECEL's 24-hour expiration time allows eligible patients to undergo TP-IAT at a qualified surgical center closer to home. Previously, TP-IAT